SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heightened activity as the market reacts to a significant share offering aimed at funding capacity expansion, with the community split between concerns over near-term dilution and bullish sentiment regarding the company's long-term AI foundry strategy. Traders are actively debating entry points and monitoring potential customer partnership announcements as key catalysts to sustain the stock's turnaround momentum.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending following a major strategic collaboration and equity investment from Boeing, which also includes the acquisition of several Boeing subsidiaries to advance their physical AI and aerospace capabilities. While bulls are excited by the potential for defense contracts and a possible short squeeze, community discussion remains polarized as some investors express concerns over dilution and the company's long-term commercialization timeline.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently under intense community scrutiny following positive topline Phase 3 IZAR-1 trial results, which showed the drug met primary and secondary endpoints in psoriatic arthritis patients. While some retail investors express frustration over perceived delays and stock price stagnation, many community members emphasize that the drug's long-term efficacy and safety profile make it a strong candidate for future acquisition, actively discussing the potential for a "best-in-class" profile as the trial remains blinded through 52 weeks.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors react to the appointment of Dr. Lynn Seely to the board and positive clinical developments surrounding its ABCL635 program. Community sentiment remains split between long-term bulls highlighting institutional accumulation and platform validation via new partnerships, and skeptics emphasizing past performance and concerns regarding pipeline execution.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors aggressively debate reports of a potential withdrawal of the company's multi-billion dollar bid to acquire eBay, with many weighing the implications of a possible partnership versus potential shareholder dilution. The community remains deeply divided, with some betting on a strategic '4D chess' move by leadership to unlock value while others express frustration over stagnant price action and the lack of official communication.

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

Tenax Therapeutics Inc

Tenax Therapeutics is experiencing significant volatility and trading volume after announcing an oversubscribed private placement to fund its clinical pipeline. The community is heavily focused on the implications of the financing structure, with discussions polarized between optimistic retail investors eyeing the potential for a short squeeze and bearish traders warning of dilution risks.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is trending due to heightened investor anticipation surrounding its upcoming Q2 earnings release and a potential short squeeze, fueled by high short interest and aggressive retail discussion regarding its pivot into AI infrastructure. The community is actively debating the impact of the Northern Data acquisition and the company's long-term cloud revenue potential against its recent price volatility.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is currently the subject of intense community debate as investors weigh strong fundamental growth and AI-platform integration against significant downward price pressure. While some traders are focused on potential short squeezes and undervalued technical setups, others remain skeptical, citing concerns over long-term AI-driven disruption in the broader software sector.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading in a state of high volatility as investors await an update on an FDA decision that has surpassed its expected deadline. The community remains deeply divided, with bulls anticipating a breakthrough and buyout potential, while bears are aggressively shorting the stock, citing ongoing concerns over potential dilution, funding risks, and the commercial viability of its therapy.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is generating intense market conversation driven by its first public earnings report and a high-profile lockup expiration that has triggered a battle between institutional index-tracking buyers and short sellers. Community sentiment is deeply divided, with bulls pointing to aggressive long-term revenue targets and AI infrastructure expansion while bears remain focused on valuation concerns, potential share dilution, and the sustainability of capital-intensive projects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
